FDA Clearance Tracker · K173294
Magnesium
Last checked: Nov 19, 2026Latest source record: May 18, 2018 (this decision)Source: openFDAMethods & limitations
Decided
May 18, 2018
Substantially Equivalent
Time to decision
214 days
Received Oct 16, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class I
The decision
- FDA number
- K173294
- Device name
- Magnesium
- Applicant
- Abbott Laboratories
- Applicant location
- Irving, TX
- Received
- Oct 16, 2017
- Decided
- May 18, 2018
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Photometric Method, Magnesium (JGJ)
- Device class
- Class I
- Regulation
- 21 CFR 862.1495
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code JGJ. The earliest in FDA's data is K771469, decided Sep 12, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K173294
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Abbott Laboratories
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Anti-HCV Next510(k)
K262156 · Decided Sep 23, 2026 · 89 days after receipt
Device type: Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus (MZO) · Laboratory Medicine & Pathology
- Anti-HCV Next510(k)
K252424 · Decided Apr 28, 2026 · 270 days after receipt
Device type: Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus (MZO) · Laboratory Medicine & Pathology
- ARCHITECT iGentamicin510(k)
K243500 · Decided Jul 9, 2025 · 239 days after receipt
Device type: Enzyme Immunoassay, Gentamicin (LCD) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.